Transcript: Jack Khouri, MD: So, Greg, we seem like a big fan of this. Craig Cole, MD: I didn’t want to tell you. But the patients that I had on [the trial] are what make me a fan. The patients I had when we had to discontinue in November had to stop therapy and remain in very good, or even CRs [complete responses] for months and months. I think the longest one is a patient I still have from November when I discontinued, and she’s still in a CR.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Craig Cole
DREAMM-3: Belantamab Mafodotin in Patients With Relapsed/Refractory MM
Transcript: Judy Schreiber, PhD, RN: We’ll go on to the next presentation, which will be Dr [Craig] Cole presenting on the DREAMM-3 study [NCT04162210]. Craig Cole, MD: Thanks, and I was just an investigator on the DREAMM-6 study [NCT03544281]. I want to thank everyone for inviting me, and Dr Weisel for sharing her slides with me. So belantamab mafodotin or Blenrep is a humanized anti-BCMA conjugated antibody.
Cross Q&A: Clinical Application of Ixa-Len-Dex for Patients With MM
Transcript: Craig Cole, MD: Faiz, where do you think you’d use a regimen like this? I think this was a French study done a few years ago. How do you think this fits into the landscape these days? Faiz Anwer, MD, FACP: I think this fits in with the more frail or [older] patients. A significant number of patients are not close to a major academic center. There’s a significant number of patients who don’t want to travel so frequently.
REMIX: Real-World Effectiveness of Ixazomib with Lenalidomide and Dexamethasone in MM
Contemporary Concepts Awareness Month Interactive Tools Nurse Practitioners/Physician's Assistants Partners Sponsored
Cross Q&A: Efficacy of CAR T-Cell Therapy in MM
Contemporary Concepts Awareness Month Interactive Tools Nurse Practitioners/Physician's Assistants Partners Sponsored
Treatment Considerations for Ponatinib in Patients With CML
Contemporary Concepts Awareness Month Interactive Tools Nurse Practitioners/Physician's Assistants Partners Sponsored
Cross Q&A: Treatment Considerations for Ixa-Pom-Dex in Multiple Myeloma
Transcript: Judy Schreiber, PhD, RN: Over to our Cleveland Clinic [team], if you have any comments or questions, or any statements you want to make related to this abstract, please feel free. Faiz Anwer, MD: I just have a question. …Who is the ideal patient eligible for this combination therapy?
CARTITUDE-4: Cilta-Cel in Lenalidomide-Refractory MM
Transcript: Judy Schreiber, PhD, RN: Let’s move on to the next abstract that will be presented by Dr Khouri, which is related to the CARTITUDE-4 study [NCT04181827]. Jack Khouri, MD: There are more exciting data on cilta-cel [ciltacabtagene autoleucel]. I’ll be presenting the results of the phase 3 CARTITUDE-4 study of cilta-cel vs standard of care with PVd [pomalidomide, bortezomib, dexamethasone] or DPd [daratumumab, pomalidomide, dexamethasone] in lenalidomide-refractory multiple myeloma [MM].
Team Introductions: MM Experts From Karmanos Cancer Institute and Cleveland Clinic
Contemporary Concepts Awareness Month Interactive Tools Nurse Practitioners/Physician's Assistants Partners Sponsored
Roadshow: 2022 Ford Maverick is basically excellent
There's nothing fancy about Ford's new compact pickup, yet it still manages to feel like far more than the sum of its parts. kAm%96 a_aa u@C5 |2G6C:4< 3=6H >6 2H2J =:<6 =2H? 7FC?:EFC6 :? 2 9FCC:42?6] x?4=F5:?8 56DE:?2E:@? 766D[ E9:D 324<\E@\32D:4D 4@>A24E ECF4< DE2CED 2E =6DD E92? Saa[___[ >2<:?8 :E 2? F?36=:6G23=6 G2=F6] qFE E96 |2G6C:4<VD 8C62E?6DD :D?VE 6I4=FD:G6=J 2 7F?4E:@? @7 E92E =@H DE2CE:?8 AC:46i xEVD 2?
Roadshow: 2021 Jeep Grand Cherokee L has a third-row seat and so much more
The Jeep Grand Cherokee is one of the most popular SUVs available today, and for good reason. Not only does it look great, this rugged vehicle provides immense off-road capability, a coddling cabin and plenty of refinement. Accordingly, whenever Jeep redesigns this mountain goat, it's big news. And for 2021, that's especially true, since the newly minted Grand Cherokee L is pumped up in stature and now comes with a standard third-row seat. kAm%96 255:E:@?
Roadshow: 2022 Ford F-150 Lightning electric pickup is a huge deal for EVs
The 2022 Ford F-150 Lightning is a segment-defining all-electric pickup truck. In fact, it's the single most consequential new vehicle in development from the Blue Oval right now. Yes, that includes the reborn Ford Bronco SUV that set the internet on fire when it debuted last year. In fact, I'm here to argue that it's not even close. I've had a look in and around this battery-powered behemoth -- heck, I've even had an early ride-along -- and I'm here to tell you why this F-Series is such a big deal.
Roadshow: 2021 Hyundai Santa Fe looks and feels like a million bucks
Proponents of trickle-down economics argue that cutting taxes for the wealthy or large corporations benefits everyone because their extra money can be invested to create more jobs or pay higher wages. Of course, it's dubious whether this actually makes any economic sense, but such a top-down approach does work in other fields, like the automotive industry. Case in point: the Hyundai Palisade.
Roadshow: 2021 Nissan Versa offers so much for so little
The average new-vehicle transaction price in the U.S. last year topped $40,000. That's an astronomical amount of money to spend on an asset that typically depreciates like property values at a superfund site. But owing a shiny new ride with a factory warranty and plenty of tech doesn't have to leave you a penniless pauper. The 2021 Nissan Versa, for instance, offers so much content for so little cash.
Roadshow: 2021 Volvo V60 Cross Country worthy of a chef's kiss
A car or truck doesn't have to be the best in every measure to be highly desirable. The 2021 Volvo V60 Cross Country isn't the most versatile vehicle available today, nor is it the quickest, fanciest or best equipped. But man, it's a terrific all-around package, one that feels like more than the sum of its Scandinavian parts. kAm#:5:?8 23@FE a]d :?496D E2==6C E92? E96 'e_ H28@?
Roadshow: 2021 Nissan Kicks offers more for your money
The Nissan Kicks is an inexpensive vehicle, but it's not cheap. Updated for 2021, this likable subcompact crossover offers loads of high-end features and plenty of interior space, all at a bargain-basement price. kAm%9:D C67C6D965 7:G6\5@@C 36?67:ED 7C@> >@C6 DE2?52C5 E649?@=@8J[ D@>6 >:?@C :?E6C:@C 492?86D 2?5[ A6C92AD >@DE D:8?:7:42?E=J[ 6?92?465 6IE6C:@C DEJ=:?8] }6H H966= 56D:8?D 2C6 @776C65[ A=FD $' 2?5 $# EC:>D 82:?
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Craig
Contact Craig, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack